Novartis International AG / . Processed and transmitted by Thomson Reuters ONE.The issuer is solely responsible for the content of this... ...
http://www.andhranews.net/Business/2013/Key-vildagliptin-data-Lancet-show-first-22651.htmRoyalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirem... Intraday Stock... ...
http://in.advfn.com/p.php?pid=nmona&article=57719031Evolutionary Medical Device Comes to the Aid of Millions Suffering from Psoriasis, Eczema, & Vitiligo PR Newswire SCHAUMBURG, Ill., May 22, 2013... ...
http://www.asianhhm.com/news/news_archives.asp?NewsID=46089&title=WCUIaposs-PsoriaShield®-Announces-Sales-RollOut-of-PsoriaLight®-to-Key-MarketsElcelyx Therapeutics has started enrollment of patients with type 2 diabetes in phase IIb dose-finding clinical trial of product candidate NewMet,... ...
http://www.pharmabiz.com/NewsDetails.aspx?aid=75483&sid=2Leading Brazilian Diagnostic Company to Market DPP(R) Products in Brazil MEDFORD, N.Y., May 21, 2013 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc.... ...
http://www.bizwireexpress.com/showstoryGNW.php?storyid=310791
0 Followers
0 Followers
0 Followers
Court Case
0 Followers